Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Hardware, Equipment & Parts
Buys12
Sells72
Buy $$12.83B
Sell $$70.69M
Ratio181.48:1
% Change vs. Prior
Ratio +5736.1%Value +960.7%
Engineering & Construction
Buys1
Sells22
Buy $$1.67K
Sell $$1.70B
Ratio1:1019972.52
Software - Infrastructure
Buys17
Sells646
Buy $$17.94M
Sell $$1.26B
Ratio1:70.36
% Change vs. Prior
Ratio -30.7%Value +25.1%
Biotechnology
Buys90
Sells974
Buy $$105.02M
Sell $$747.93M
Ratio1:7.12
% Change vs. Prior
Ratio -2.6%Value +3.4%
Specialty Retail
Buys18
Sells288
Buy $$776.21K
Sell $$637.78M
Ratio1:821.66
% Change vs. Prior
Ratio -99.3%Value -43.2%
Computer Hardware
Buys1
Sells144
Buy $$61.11K
Sell $$523.33M
Ratio1:8563.55
% Change vs. Prior
Ratio -79.1%Value -16.6%
Semiconductors
Buys34
Sells326
Buy $$819.60K
Sell $$496.54M
Ratio1:605.83
% Change vs. Prior
Ratio -1.3%Value -15.5%
Communication Equipment
Buys0
Sells81
Buy $$0.00
Sell $$321.13M
RatioAll Sells
Renewable Utilities
Buys2
Sells10
Buy $$58.37K
Sell $$314.44M
Ratio1:5387.07
Shell Companies
Buys29
Sells79
Buy $$20.33M
Sell $$247.11M
Ratio1:12.16
Software - Application
Buys16
Sells256
Buy $$37.22M
Sell $$194.30M
Ratio1:5.22
% Change vs. Prior
Ratio -46.7%Value -81.0%
Oil & Gas Equipment & Services
Buys2
Sells26
Buy $$62.47K
Sell $$207.01M
Ratio1:3313.58
% Change vs. Prior
Ratio -83.4%Value -57.8%
Oil & Gas Refining & Marketing
Buys0
Sells29
Buy $$0.00
Sell $$184.20M
RatioAll Sells
Oil & Gas Exploration & Production
Buys43
Sells47
Buy $$5.31M
Sell $$164.43M
Ratio1:30.99
% Change vs. Prior
Ratio +999.0%Value -94.3%
Aerospace & Defense
Buys1
Sells95
Buy $$9.84K
Sell $$121.52M
Ratio1:12349.67
% Change vs. Prior
Ratio -99.4%Value -88.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
323
Price
$566.82
Total Value
$183.08K
Shares Held After
19,516
% of Holdings
1.6%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
742
Price
$565.99
Total Value
$419.97K
Shares Held After
19,839
% of Holdings
3.6%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
2,201
Price
$564.82
Total Value
$1.24M
Shares Held After
20,581
% of Holdings
9.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
896
Price
$563.86
Total Value
$505.22K
Shares Held After
22,782
% of Holdings
3.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
555
Price
$563.00
Total Value
$312.46K
Shares Held After
23,678
% of Holdings
2.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
571
Price
$561.75
Total Value
$320.76K
Shares Held After
24,233
% of Holdings
2.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
72
Price
$560.39
Total Value
$40.35K
Shares Held After
24,804
% of Holdings
0.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
240
Price
$559.03
Total Value
$134.17K
Shares Held After
24,876
% of Holdings
1.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
720
Price
$558.11
Total Value
$401.84K
Shares Held After
25,116
% of Holdings
2.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
977
Price
$557.05
Total Value
$544.23K
Shares Held After
25,836
% of Holdings
3.6%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
844
Price
$556.17
Total Value
$469.41K
Shares Held After
26,813
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
778
Price
$555.22
Total Value
$431.96K
Shares Held After
27,657
% of Holdings
2.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
401
Price
$553.99
Total Value
$222.15K
Shares Held After
28,435
% of Holdings
1.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 2, 2026
Sale
Shares
40
Price
$551.86
Total Value
$22.07K
Shares Held After
28,836
% of Holdings
0.1%
Apr 2, 2026
Sale
Shares
120
Price
$571.66
Total Value
$68.60K
Shares Held After
40,513
% of Holdings
0.3%
Apr 2, 2026
Sale
Shares
80
Price
$570.05
Total Value
$45.60K
Shares Held After
40,633
% of Holdings
0.2%
Apr 2, 2026
Sale
Shares
120
Price
$568.53
Total Value
$68.22K
Shares Held After
40,713
% of Holdings
0.3%
Apr 2, 2026
Sale
Shares
308
Price
$567.70
Total Value
$174.85K
Shares Held After
40,833
% of Holdings
0.7%
Apr 2, 2026
Sale
Shares
570
Price
$566.39
Total Value
$322.84K
Shares Held After
41,141
% of Holdings
1.4%
Apr 2, 2026
Sale
Shares
811
Price
$565.38
Total Value
$458.52K
Shares Held After
41,711
% of Holdings
1.9%
Apr 2, 2026
Sale
Shares
1,918
Price
$564.55
Total Value
$1.08M
Shares Held After
42,522
% of Holdings
4.3%
Apr 2, 2026
Sale
Shares
865
Price
$563.52
Total Value
$487.45K
Shares Held After
44,440
% of Holdings
1.9%
Apr 2, 2026
Sale
Shares
378
Price
$562.49
Total Value
$212.62K
Shares Held After
45,305
% of Holdings
0.8%
Apr 2, 2026
Sale
Shares
570
Price
$561.60
Total Value
$320.11K
Shares Held After
45,683
% of Holdings
1.2%
Apr 2, 2026
Sale
Shares
40
Price
$559.98
Total Value
$22.40K
Shares Held After
46,253
% of Holdings
0.1%
Apr 2, 2026
Sale
Shares
440
Price
$558.51
Total Value
$245.74K
Shares Held After
46,293
% of Holdings
0.9%
Apr 2, 2026
Sale
Shares
780
Price
$557.40
Total Value
$434.77K
Shares Held After
46,733
% of Holdings
1.6%
Apr 2, 2026
Sale
Shares
808
Price
$556.52
Total Value
$449.67K
Shares Held After
47,513
% of Holdings
1.7%
Apr 2, 2026
Sale
Shares
1,058
Price
$555.41
Total Value
$587.62K
Shares Held After
48,321
% of Holdings
2.1%
Apr 2, 2026
Sale
Shares
394
Price
$554.45
Total Value
$218.46K
Shares Held After
49,379
% of Holdings
0.8%
Apr 2, 2026
Sale
Shares
175
Price
$553.50
Total Value
$96.86K
Shares Held After
49,773
% of Holdings
0.4%
Apr 2, 2026
Sale
Shares
65
Price
$552.25
Total Value
$35.90K
Shares Held After
49,948
% of Holdings
0.1%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Milanova Tsveta — Chief Commercial Officer
Apr 2, 2026
Sale
Shares
3,262
Price
$34.71
Total Value
$113.22K
Shares Held After
46,829
% of Holdings
6.5%
Shares
2,494
Price
$206.22
Total Value
$514.31K
Shares Held After
1,926,119
% of Holdings
0.1%
Shares
1,848
Price
$205.64
Total Value
$380.02K
Shares Held After
1,928,613
% of Holdings
0.1%
Shares
1,729
Price
$204.50
Total Value
$353.58K
Shares Held After
1,930,461
% of Holdings
0.1%
Shares
1,864
Price
$203.52
Total Value
$379.35K
Shares Held After
1,932,190
% of Holdings
0.1%
Shares
1,662
Price
$202.58
Total Value
$336.68K
Shares Held After
1,934,054
% of Holdings
0.1%
Shares
357
Price
$201.43
Total Value
$71.91K
Shares Held After
1,935,716
% of Holdings
0.0%
Shares
46
Price
$200.97
Total Value
$9.24K
Shares Held After
1,936,073
% of Holdings
0.0%
Shares
6,149
Price
$101.45
Total Value
$623.82K
Shares Held After
228,460
% of Holdings
2.6%

Credo Technology Group Holding Ltd (CRDO)

Fleming Daniel W. — Chief Financial Officer
Apr 2, 2026
Sale
Shares
2,460
Price
$101.45
Total Value
$249.57K
Shares Held After
443,718
% of Holdings
0.6%
Apr 2, 2026
Sale
Shares
3,180
Price
$101.45
Total Value
$322.61K
Shares Held After
2,613,509
% of Holdings
0.1%

DoorDash, Inc. (DASH)

Tang Stanley — Director
Apr 2, 2026
Sale
Shares
21,433
Price
$150.00
Total Value
$3.21M
Shares Held After
0
% of Holdings
100.0%

DoorDash, Inc. (DASH)

Tang Stanley — Director
Apr 2, 2026
Sale
Shares
1,692
Price
$150.00
Total Value
$253.80K
Shares Held After
19,279
% of Holdings
8.1%

Vericel Corp (VCEL)

Hopper Jonathan Mark — Chief Medical Officer
Apr 2, 2026
Sale
Shares
3,472
Price
$35.00
Total Value
$121.52K
Shares Held After
75,556
% of Holdings
4.4%
Apr 2, 2026
Sale
Shares
6,596
Price
$34.71
Total Value
$228.95K
Shares Held After
184,508
% of Holdings
3.5%
Apr 2, 2026
Sale
Shares
12,472
Price
$34.71
Total Value
$432.90K
Shares Held After
177,604
% of Holdings
6.6%

Privia Health Group, Inc. (PRVA)

Mountcastle David — EVP & Chief Financial Officer
Apr 2, 2026
Sale
Shares
5,566
Price
$20.85
Total Value
$116.05K
Shares Held After
214,847
% of Holdings
2.5%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Viswanadhan Krishnan — Chief Corp Dev & Strategy
Apr 2, 2026
Sale
Shares
2,959
Price
$34.71
Total Value
$102.71K
Shares Held After
10,282
% of Holdings
22.3%
Version: v26.3.33